Wesley Wheeler

Wesley Potter Wheeler is currently Chairman at Biotouch, Inc., Non-Executive Director at Mallinckrodt Pharmaceuticals Ireland Ltd. since 2024, Director at De Facto 1341 Ltd., Maze 3 Ltd., Marken Services Ltd., Maze 1 Ltd., Marken Time Critical Express Ltd. since 2011, Marken (South America) Ltd. since 2017, X4i Ltd. since 2019, Argenta Holdings Ltd., and Independent Member-Supervisory Board at Evotec SE since 2024.
Former roles include President & Chief Executive Officer at DSM Pharmaceuticals, Inc. from 2002 to 2003; Chief Executive Officer at UPS Supply Chain Solutions, Inc.; President, Chief Executive Officer & Director at Patheon, Inc. in 2009; Chief Executive Officer & Director at Marken Ltd. from 2011 to 2020; Chief Executive Officer at Pharmetics (2011), Inc.; Chief Executive Officer & Director at LabConnect, Inc. from 2024 to 2026; Outside Director at Bushu Pharmaceuticals Ltd. from 2017 to 2019; Independent Director at Keenova Therapeutics Plc from 2024 to 2025; Director at Envirotainer AB; President-Research & Development at Bausch Health Americas, Inc. and Bausch Health Cos., Inc. from 2003 to 2007; President-Global Healthcare & Life Sciences at United Parcel Service, Inc. from 2019 to 2023; Vice President-Marketing at Glaxo Wellcome Plc; Senior Vice-President-Logistics & Strategy at GSK Plc; and President at UPS Healthcare.
Italia.
Srl from 2020 to 2023.
Education includes an MBA from California Lutheran University and undergraduate studies at Worcester Polytechnic Institute.